JMPWA
ITOS

JP Morgan Private Wealth Advisors’s iTeos Therapeutics ITOS Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$175K Hold
15,979
– – ﹤0.01% 1646
2023
Q2 		$212K Hold
15,979
– – ﹤0.01% 1370
2023
Q1 		$217K Sell
15,979
-4,825
-23% -$86.4K ﹤0.01% 1799
2022
Q4 		$406K Hold
20,804
– – ﹤0.01% 1552
2022
Q3 		$396K Hold
20,804
– – ﹤0.01% 1547
2022
Q2 		$429K Sell
20,804
-21
-0.1% -$498 ﹤0.01% 1515
2022
Q1 		$670K Sell
20,825
-2,792
-12% -$101K ﹤0.01% 1399
2021
Q4 		$1.1M Buy
+23,617
New +$786K ﹤0.01% 1197

Other funds holding ITOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ITOS Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors held its iTeos Therapeutics (ITOS) position steady in Q3 2023 at 15,979 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1646.

JP Morgan Private Wealth Advisors first reported a position in ITOS in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.1M in Q4 2021. 144 funds tracked by Wall St. Rank hold ITOS as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 15,979 shares of iTeos Therapeutics worth $175K as of Q3 2023.
  • JP Morgan Private Wealth Advisors left its iTeos Therapeutics share count unchanged in Q3 2023.
  • iTeos Therapeutics made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1646 holding.
  • JP Morgan Private Wealth Advisors first reported a position in iTeos Therapeutics in Q4 2021 and has held it in 8 quarters since.
  • JP Morgan Private Wealth Advisors's iTeos Therapeutics position peaked at $1.1M in Q4 2021.
  • 144 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.